道琼斯指数
51,786.72
涨跌
-197.26-0.38%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 -0.38%,标普 500 指数为 +0.36%,纳斯达克综合指数为 +0.83%。个股方面,435 只上涨、4,615 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 1 | 安进AMGN | $461.27 | +1.05% | 7.98K | $249.38B | $294.48 - $475.64 | 0.02% |
| 2 | 吉利德科学GILD | $169.08 | +1.13% | 6.20K | $209.72B | $116.88 - $175.65 | 0.02% |
| 3 | ModernaMRNA | $232.53 | +2.00% | 69.63K | $92.84B | $22.28 - $254.48 | 0.00% |
| 4 | IQVIA HoldingsIQV | $267.00 | +1.72% | 44 | $44.00B | $154.50 - $284.50 | 0.00% |
| 5 | Revolution MedRVMD | $196.71 | +1.26% | 1.16K | $42.16B | $57.74 - $224.31 | 0.00% |
| 6 | BiogenBIIB | $248.59 | -0.40% | 201 | $36.75B | $148.51 - $258.78 | 0.00% |
| 7 | 因塞特医疗INCY | $118.05 | +0.40% | 223 | $24.06B | $89.25 - $132.60 | 0.00% |
| 8 | MedpaceMEDP | $664.68 | +0.06% | 0 | $18.59B | $373.00 - $693.97 | 0.00% |
| 9 | 伊克力西斯EXEL | $72.15 | -0.48% | 4.09K | $17.61B | $37.58 - $73.98 | 0.00% |
| 10 | 神经分泌生物科学NBIX | $169.34 | +4.44% | 335 | $17.21B | $122.14 - $186.12 | 0.00% |
| 11 | 查尔斯河CRL | $357.11 | +1.46% | 488 | $17.05B | $146.19 - $379.63 | 0.00% |
| 12 | 奥洛兹美医疗HALO | $129.04 | +0.81% | 275 | $14.65B | $61.23 - $134.00 | 0.00% |
| 13 | Bio-TechneTECH | $72.66 | -0.08% | 2.59M | $11.41B | $43.20 - $72.75 | 0.00% |
| 14 | KymeraKYMR | $129.80 | +0.76% | 10 | $11.08B | $55.66 - $133.88 | 0.00% |
| 15 | RepligenRGEN | $178.40 | +3.11% | 618.82K | $10.07B | $100.99 - $198.87 | 0.00% |
| 16 | VaxcytePCVX | $61.43 | +1.11% | 259 | $9.14B | $39.87 - $90.75 | 0.00% |
| 17 | Krystal BiotechKRYS | $305.06 | -1.75% | 1 | $9.03B | $192.52 - $382.54 | 0.00% |
| 18 | Twist BioscienceTWST | $143.73 | +2.82% | 7.78K | $9.01B | $23.30 - $219.71 | 0.00% |
| 19 | ImmunitybioIBRX | $8.40 | +1.39% | 18.57K | $8.91B | $1.95 - $12.43 | 0.00% |
| 20 | Kodiak SciencesKOD | $99.61 | 0.00% | 45 | $6.26B | $15.83 - $104.00 | 0.00% |
| 21 | ImmunovantIMVT | $29.04 | -0.47% | 2 | $6.00B | $21.43 - $45.42 | 0.00% |
| 22 | CG OncologyCGON | $64.14 | 0.00% | 6 | $5.69B | $35.80 - $80.97 | 0.00% |
| 23 | Scholar RockSRRK | $44.86 | -0.01% | 0 | $5.46B | $27.07 - $61.76 | 0.00% |
| 24 | Crispr TherapeuticsCRSP | $51.02 | +2.26% | 5.98K | $4.93B | $44.12 - $63.45 | 0.00% |
| 25 | Iovance BiotherapeuticsIOVA | $9.14 | +4.13% | 25.75K | $4.14B | $1.76 - $15.37 | 0.00% |
| 26 | Adaptive BiotechnologiesADPT | $25.80 | 0.00% | 397 | $4.12B | $12.00 - $30.74 | 0.00% |
| 27 | Relay TherapeuticsRLAY | $17.45 | -1.45% | 30 | $3.82B | $5.95 - $21.27 | 0.00% |
| 28 | TarsusTARS | $73.25 | 0.00% | 337 | $3.61B | $53.89 - $91.53 | 0.00% |
| 29 | Denali TherapeuticsDNLI | $19.50 | -4.80% | 164 | $3.12B | $13.75 - $27.30 | 0.00% |
| 30 | BeamBEAM | $27.21 | +3.04% | 1.07K | $2.81B | $20.23 - $38.26 | 0.00% |
| 31 | ADMA BiologicsADMA | $11.10 | +0.33% | 2 | $2.49B | $7.21 - $20.46 | 0.00% |
| 32 | BioCryst制药BCRX | $8.52 | 0.00% | 117 | $2.18B | $6.23 - $11.22 | 0.00% |
| 33 | VericelVCEL | $41.11 | 0.00% | 411 | $2.11B | $28.95 - $49.32 | 0.00% |
| 34 | Recursion PharmaceuticalsRXRX | $3.81 | +2.58% | 378.05K | $2.04B | $2.77 - $5.32 | 0.00% |
| 35 | ReplimuneREPL | $20.80 | +1.16% | 759 | $1.97B | $1.50 - $21.26 | 0.00% |
| 36 | Hemab TherapeuticsCOAG | $43.12 | +4.69% | 369.09K | $1.94B | $23.00 - $55.42 | 0.00% |
| 37 | Vir BiotechVIR | $11.20 | -2.69% | 1.23K | $1.89B | $4.82 - $12.19 | 0.00% |
| 38 | AbsciABSI | $10.29 | +1.88% | 9.20K | $1.77B | $2.24 - $12.54 | 0.00% |
| 39 | Maze TherapeuticsMAZE | $31.80 | -1.46% | 169 | $1.75B | $21.95 - $53.65 | 0.00% |
| 40 | 诺瓦瓦克斯医药NVAX | $9.91 | +2.75% | 13.81K | $1.64B | $6.20 - $13.38 | 0.00% |
| 41 | Taysha GeneTSHA | $4.04 | 0.00% | 25 | $1.32B | $3.46 - $7.30 | 0.00% |
| 42 | Vor BiopharmaVOR | $20.29 | +1.69% | 379 | $1.25B | $6.50 - $26.00 | 0.00% |
| 43 | Inhibrx BiosciencesINBX | $81.17 | +12.51% | 355.52K | $1.19B | $57.30 - $155.29 | 0.00% |
| 44 | Cullinan Oncology LLCCGEM | $15.12 | -6.18% | 102 | $973.04M | $6.73 - $23.19 | 0.00% |
| 45 | Odyssey TherapeuticsODTX | $21.58 | +10.57% | 359.89K | $939.06M | $15.10 - $29.05 | 0.00% |
| 46 | Monte Rosa TherapeuticsGLUE | $10.75 | +2.27% | 1.07K | $917.12M | $9.68 - $25.77 | 0.00% |
| 47 | MeiraGTxMGTX | $9.52 | -0.37% | 0 | $914.43M | $6.62 - $15.35 | 0.00% |
| 48 | Prime MedicinePRME | $4.48 | -0.99% | 3.97K | $813.29M | $2.67 - $5.91 | 0.00% |
| 49 | OmniAbOABI | $5.30 | -0.06% | 677 | $772.91M | $1.30 - $5.43 | 0.00% |
| 50 | Sana BiotechnologySANA | $2.44 | +0.12% | 1.11K | $731.64M | $2.22 - $5.49 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。